Robert Peter Gale
Robert Peter Gale was born in New York City in 1945. He received his A.B. degree with high honors in biology and chemistry from Hobart College, NY, USA, in 1966, and his M.D. degree from the State University of New York at Buffalo, NY, USA. His postgraduate medical training (internal medicine, hematology, and oncology) was at the University of California, Los Angeles (UCLA) from 1970 to 1973. In 1976, he received the Ph.D. degree in microbiology and immunology from UCLA. From 1973 to 1993, he was on the Faculty of the UCLA School of Medicine, where he focused on the molecular biology, immunology, and treatment of leukemia. He has published over 800 scientific articles and more than 20 books, mostly on leukemia (biology and treatment), transplantation (biology, immunology, and treatment), cancer immunology, and radiation (biological effects and accident response). From 1980 to 1997,he served as the Chairman of the Scientific Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR). Since 1989, he has been a Member of the Scientific Advisory Board of the Autologous Blood and Marrow Transplant Registry (ABMTR). From 1989 to 2003, he chaired the Scientific Advisory Board of the Center for Advanced Studies in Leukemia. Moreover, he has received several awards for his humanitarian activities including the Olender Peace Prize, City of Los Angeles Humanitarian Award, and Myasthenia Gravis Foundation Humanitarian Award. In 2007, he joined Celgene Corporation, where he works as the Executive Director of clinical research, hematology, and oncology. His activities include development and execution of clinical trials in blood and bone marrow cancers, transplantation, and immune disorders. Leukemia and other bone marrow disorders are the central theme of his basic scientific and clinical research for over 35 years. In addition, he serves presently a Visiting Professor of hematology at the Imperial College at Hammersmith Hospital, London, UK.
Biography Updated on 28 August 2011